Optilume drug-coated balloon for anterior urethral stricture: 2-year results of the ROBUST III trial.

Journal: BJUI compass
Published Date: Dec 18, 2023

Abstract

OBJECTIVE: The aim of this study is to report the updated 2-year results of the intervention arm of the ROBUST III randomized trial evaluating the safety and efficacy of the Optilume drug-coated balloon (DCB) versus standard endoscopic management of recurrent male anterior urethral stricture.

Authors

  • Maia E VanDyke
    UT Southwestern Medical Center Dallas Texas USA.
  • Allen F Morey
    UT Southwestern Medical Center Dallas Texas USA.
  • Karl Coutinho
    New Jersey Urology LLC Millburn New Jersey USA.
  • Kaiser J Robertson
    Chesapeake Urology Hanover Maryland USA.
  • Richard D'Anna
    Arkansas Urology Little Rock Arkansas USA.
  • Kent Chevli
    Western New York Urology Associates Cheektowaga New York USA.
  • Christopher H Cantrill
    Urology San Antonio San Antonio Texas USA.
  • Michael J Ehlert
    Metro Urology, a division of Minnesota Urology Woodbury Minnesota USA.
  • Alexis E Te
    Weill Cornell Medicine New York New York USA.
  • Jeffrey Dann
    Advanced Urology Institute Daytona Beach Florida USA.
  • Jessica M DeLong
    MultiCare Urology Puyallup Washington USA.
  • Ramón Virasoro
    Surgical Services, Section of Urology VA Eastern Colorado Health Care System Aurora Colorado USA.
  • Judith C Hagedorn
    University of Washington Seattle Washington USA.
  • Richard Levin
    Chesapeake Urology Research Associates Annapolis Maryland USA.
  • Euclid DeSouza
    Adult and Pediatric Urology PC Omaha Nebraska USA.
  • David DiMarco
    Oregon Urology Institute Springfield Oregon USA.
  • Brad A Erickson
    University of Iowa Hospitals and Clinics Iowa City Iowa USA.
  • Carl Olsson
    Integrated Medical Professionals New York New York USA.
  • Sean P Elliott
    University of Minnesota Minneapolis Minnesota USA.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals